Premium Content

Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

• Kansas-based pharmaceutical technology company develops customized formulations and intellectual property • Deal includes platforms that can be dosed in oral, injectable and otic (ear) formulations • Acquisition expands Adare’s technology platforms and product development capabilities

Please sign in or register for FREE

Register to DDF Digital

Register

No comments yet.